Surveillance of communicable diseases in Europe – a concept to integrate molecular typing data into EU-level surveillance
In 2010, ECDC proposed a concept on how to integrate molecular typing data and surveillance at the EU level by taking into account the structures developed by the former dedicated surveillance networks (DSNs) and in other networks, in line with the overall ECDC public health microbiology strategy.
This 2011 document outlines the principles for the gradual integration of molecular typing data and methods into the European Surveillance System (TESSy) and serves as a general guidance for the key stakeholders in the Member States, EC, and ECDC.
COVID-19 Aviation Health Safety Protocol: Guidance for the management of airline passengers in relation to the COVID-19 pandemic
20 May 2020 - The purpose of these guidelines is to serve as an aviation health safety protocol and to provide a source of best practice on how airport operators, aeroplane operators conducting commercial and non-commercial passenger transport operations (hereinafter aeroplane operators) and national aviation authorities can ensure the health and safety of passengers, as well as the staff and crew who serve them, by maintaining safe and secure operations whilst minimising the risk of virus transmission.
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
30 Mar 2020 - This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
Toolkit to support the generation of robust estimates of hepatitis C prevalence
5 Mar 2020 - European surveillance data show on-going transmission of viral hepatitis across the European Union and European Economic Area (EU/EEA). The available notification data however, do not provide a clear epidemiological picture of hepatitis C in Europe. Prevalence data from population surveys are a key source of information to complement the surveillance data for hepatitis C due to the limitations of surveillance for hepatitis: the infection is often asymptomatic and notifications are strongly influenced by local testing practices. The overarching aim of this toolkit is to gain a better understanding of the HCV epidemiology in the EU/EEA.